This article is more than 5 years old. Information may no longer be current.

Eye Tech Care closes €25 million funding with Everpine Capital

Issue: January 2016

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Eye Tech Care has closed a funding and partnership agreement with Everpine Capital, a Chinese investor, according to a press release.

Under the partnership, Everpine will invest a total of €25 million and support Eye Tech Care in its international expansion.

“This funding is an important milestone for us in two aspects: In addition to allowing us to strengthen our commercial expansion in European markets based on the new product generation that we launched in 2015, I am pleased to see our strategic priority on accessing the Chinese market confirmed by Everpine’s strong commitment,” Dietrich Wolf, CEO of Eye Tech Care, said in the release.

The EyeOP1, the company’s first commercial medical device, uses ultrasound to noninvasively treat glaucoma.